Fate Therapeutics
FATE
#9566
Rank
A$0.16 B
Marketcap
A$1.39
Share price
-9.01%
Change (1 day)
-14.72%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: A$0.16 Billion

As of November 2026 Fate Therapeutics has a market cap of A$0.16 Billion. This makes Fate Therapeutics the world's 9566th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.16 B-1.91%
2025A$0.17 B-41.58%
2024A$0.29 B-45.54%
2023A$0.54 B-62.43%
2022A$1.44 B-81.31%
2021A$7.70 B-25.3%
2020A$10.31 B387.4%
2019A$2.11 B79.66%
2018A$1.17 B185.99%
2017A$0.41 B185.87%
2016A$0.14 B8.48%
2015A$0.13 B5.08%
2014A$0.12 B-12.12%
2013A$0.14 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Fate Therapeutics was reported to be:

A$0.16 Billion
by Nasdaq info icon info icon
A$0.16 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Becton Dickinson
BDX
A$87.56 B 51,732.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$2.15 B 1,178.36%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$7.12 B 4,115.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$23.02 B 13,529.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A$16.99 B 9,960.12%๐Ÿ‡บ๐Ÿ‡ธ USA